How FDA Policies Ignited America's Opioid Crisis: Insights from Dr. Andrew Kolodny
We learned that the revolving door between big pharma and government has helped the opioid epidemic spiral out of control, as influential government and agency committee members have gone to work for the pharmaceutical industry and lobbying firms, sometimes within weeks of playing a key role in decisions favoring industry.
Imagine a health crisis so severe that it reshaped the very fabric of American society. In this eye-opening episode of Cover2 Resources, Dr. Andrew Kolodny sheds light on the FDA's role in fueling the opioid epidemic. As a Senior Scientist and Co-Director of Opioid Policy Research at the Heller School for Social Policy and Management, Dr. Kolodny brings a wealth of knowledge and a candid perspective to the discussion.
He explores how the FDA's approval of Purdue Pharma's OxyContin marketing tactics, along with the revolving door between big pharma and government, played pivotal roles in this catastrophe. Dr. Kolodny doesn't just point fingers; he dives into the manipulation of opioid trial methods that made these drugs appear more effective than they truly are. This episode is a must-listen for anyone seeking to understand the roots of America's opioid crisis and the systemic issues that allowed it to flourish. Dr.
Kolodny also emphasizes the importance of preventing opioid addiction and ensuring access to effective treatment. Whether you're personally affected by addiction or simply interested in public health, this episode offers valuable insights and practical advice.